Bench-to-bedside review: Genetic influences on meningococcal disease

Critical Care

Volumn 6, Issue 1, 2002, Pages 60-65

  Vermont, Clementien L ^a   de Groot, Ronald ^a   Hazelzet, Jan A ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Genetic polymorphisms; Meningococcal sepsis; Review

Indexed keywords

CD14 ANTIGEN; COMPLEMENT; CYTOKINE; FC RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNOSE BINDING PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

CAUSE OF DEATH; DISEASE COURSE; DISEASE TRANSMISSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INFECTION SENSITIVITY; MENINGOCOCCOSIS; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 0036174962     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1454     Document Type: Review

References (56)

1. Meningococcal disease
2. Underestimation of meningococci in tonsillar tissue by nasopharyngeal swabbing
3. Meningococcal disease in the Republic of Ireland: 1995
4. Bacterial Meningitis in the Netherlands. Annual Report 1999
5. Genetic and environmental influences on premature death in adult adoptees
6. Genetic dissection of the molecular pathogenesis of severe infection
7. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria
8. Variations in the expression of pili: The effect on adherence of Neisseria meningitidis to human epithelial and endothelial cells
9. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae
10. Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors
11. Interaction of Neisseria meningitidis with human nasopharyngeal mucosa: Attachment and entry into columnar epithelial cells
12. Effect of smoking on meningococcal carriage
13. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding
14. Fc gamma receptor lla (CD32) polymorphism in fulminant meningococcal septic shock in children
15. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma Rlla polymorphism to IgG2
16. Association of human Fc gamma Rlla (CD32) polymorphism with susceptibility to and severity of meningococcal disease
17. Meningococcal disease and polymorphism of FcgammaRlla (CD32) in late complement component-deficient individuals
18. The role of Fcgamma receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals
19. Infectious diseases associated with complement deficiencies
20. A second serine protease associated with mannan-binding lectin that activates complement
21. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene
22. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein
23. Molecular basis of opsonic defect in immunodeficient children
24. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype
25. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease
26. Structure and function of lipopolysaccharide binding protein
27. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
28. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition
29. Genetic and physical mapping of the Lps locus: Identification of the toll-4 receptor as a candidate gene in the critical region
30. Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity
31. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
32. LPS induction of gene expression in human monocytes
33. Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: Gender-specific genetic predisposition to sepsis
34. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
35. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans
36. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2
37. Recombinant bactericidal/permeability-increasing protein (rBPl21) as adjunctive treatment for children with severe meningococcal sepsis: A randomised trial
38. Genetic influence on cytokine production and fatal meningococcal disease
39. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease
40. Release of tumor necrosis factor: An innate host characteristic that may contribute to the outcome of meningococcal disease
41. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis
42. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease
43. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease
44. Relevance of the tumor necrosis factor alpha (TNF alpha)-308 promoter polymorphism in TNF alpha gene regulation
45. Comparison of two polymorphisms of the interleukin-1 gene family: Interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis
46. Increased plasma levels of interleukin-6 in sepsis
47. Markers of systemic inflammation predicting organ failure in community-acquired septic shock
48. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis
49. G to C transition in the promotor region of the IL6 gene is associated with disease outcome in meningococcal sepsis
50. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome
51. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells
52. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock
53. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease
54. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
55. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients
56. Hemostatic gene polymorphisms and meningococcal sepsis